<div id="readability-page-1"><p>AustralianSuper Pty Ltd lowered its stake in  Waters Co. (NYSE:WAT - Free Report) by 40.4% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor  owned 8,378 shares of the medical instruments supplier's stock after selling 5,683 shares during the quarter. AustralianSuper Pty Ltd's holdings in Waters were worth $3,015,000 as of its most recent filing with the SEC.</p><ul><li>Agilent Technologies Thrives From the Forever Chemicals Crackdown</li></ul><p>Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. SG Americas Securities LLC lifted its holdings in  Waters by 55.1% in the 1st quarter. SG Americas Securities LLC now owns 14,765 shares of the medical instruments supplier's stock worth $5,083,000 after buying an additional 5,248 shares in the last quarter.  TD Asset Management Inc boosted its holdings in  Waters by 4.3% in the first quarter. TD Asset Management Inc now owns 443,493 shares of the medical instruments supplier's stock valued at $152,664,000 after purchasing an additional 18,274 shares during the last quarter.  Mediolanum International Funds Ltd purchased a new position in  Waters in the first quarter valued at about $1,786,000.  Swedbank AB acquired a new stake in  Waters during the 1st quarter valued at approximately $10,106,000.  Finally, Bessemer Group Inc. increased its holdings in  Waters by 67.5% during the 1st quarter. Bessemer Group Inc. now owns 10,382 shares of the medical instruments supplier's stock worth $3,574,000 after purchasing an additional 4,184 shares during the last quarter. 94.01% of the stock is owned by institutional investors and hedge funds. </p><h2>Waters Stock Down 1.2 %</h2><p>Shares of Waters stock opened at $322.57 on Friday. Waters Co. has a 1-year low of $234.04 and a 1-year high of $367.21. The company has a market capitalization of $19.15 billion, a P/E ratio of 32.13, a PEG ratio of 6.42 and a beta of 0.95. The business's fifty day moving average price is $341.42 and its two-hundred day moving average price is $324.75. The company has a debt-to-equity ratio of 1.42, a current ratio of 2.10 and a quick ratio of 1.42. </p><ul><li>Medical Stocks Waters, Agilent, Illumina Show Growth Potential</li></ul><p>Waters (NYSE:WAT - Get Free Report) last posted its quarterly earnings data on Wednesday, July 31st. The medical instruments supplier reported $2.63 earnings per share for the quarter, topping the consensus estimate of $2.55 by $0.08. The business had revenue of $709.00 million during the quarter, compared to the consensus estimate of $700.09 million. Waters had a net margin of 20.71% and a return on equity of 56.81%. The company's quarterly revenue was down 4.3% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.80 earnings per share.  As a group, research analysts forecast that  Waters Co. will post 11.6 EPS for the current year. </p><h2>Wall Street Analyst Weigh In</h2><p>WAT has been the subject of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft decreased their price target on shares of Waters from $330.00 to $310.00 and set a &#34;hold&#34; rating for the company in a research report on Thursday, August 1st. Wells Fargo &amp; Company started coverage on shares of Waters in a research report on Tuesday, August 27th. They issued an &#34;overweight&#34; rating and a $380.00 target price for the company. TD Cowen increased their price target on shares of Waters from $325.00 to $363.00 and gave the stock a &#34;hold&#34; rating in a research report on Thursday, August 1st. Leerink Partnrs upgraded Waters from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research note on Thursday, August 1st. Finally, Barclays upped their price objective on Waters from $300.00 to $330.00 and gave the company an &#34;underweight&#34; rating in a research note on Tuesday, October 15th. One analyst  has rated the stock with a sell rating, nine have issued  a hold rating, three have issued  a buy rating and one  has issued  a strong buy rating to the stock. According to data from MarketBeat.com, Waters presently has an average rating of &#34;Hold&#34; and a consensus target price of $342.58.</p><p><b>Read Our Latest Stock Analysis on Waters</b></p><h2>Waters Profile</h2> (Free Report)<p>Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.</p><h2>Further Reading</h2><ul><li>Five stocks we like better than Waters</li><li>How to Use the MarketBeat Excel Dividend Calculator</li><li>Microsoft Can Hit New All-Time Highs This Year - Here’s Why</li><li>What Investors Need to Know About Upcoming IPOs</li><li>Zillow Stock’s Bull Case: Why This Recent Sell-Off Could Be a Buy</li><li>Why Special Dividends Can be a Delightful Surprise for Income Investors</li><li>IonQ’s Quantum Surge: Ride the Wave or Cash Out?</li></ul><p><strong>Want to see what other hedge funds are holding WAT?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVdBVA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVdBVA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><p>→ I was wrong. Dead wrong.  <span><span>(From Porter &amp; Company)</span> <span>(Ad)</span></span><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDIyMg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" height="1" width="1" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDIyMg"/></p><h2>Should you invest $1,000 in Waters right now?</h2><p>Before you consider Waters, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waters wasn't on the list.</p><p>While Waters currently has a &#34;Hold&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>AustralianSuper Pty Ltd reduced its stake in Waters Co. (NYSE:WAT) by 40.4% in Q3, now holding 8,378 shares valued at $1,015,000. Other institutional investors have also adjusted their positions, with SG Americas increasing its stake by 55.1%. Waters shares opened at $75.57, down 1.2%, with a market cap of $15.15 billion. The company reported Q2 earnings of $1.63 per share, exceeding estimates, but revenue fell 4.3% year-over-year. Analysts have mixed ratings on the stock, with an average rating of "Hold" and a consensus target price of $78.58.</p>

Waters Co. (NYSE:WAT) Shares Sold by AustralianSuper Pty Ltd